Search results for "Infectious Diseases"
February 23, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/02/23/
CMS sepsis measure associated with increases in antibiotic use
Use of broad-spectrum antibiotics, especially in sepsis patients, went up after SEP-1 was implemented, but rates of Clostridioides difficile infection decreased.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/5.htm
2 Sep 2020
January 26, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/01/26/
Telemedicine ID consults reduced length of stay for patients with active infections
Remote inpatient infectious disease (ID) consultations also reduced antibiotic days and costs, signifying an antimicrobial stewardship effect, researchers wrote.
https://acphospitalist.acponline.org/weekly/archives/2019/05/01/2.htm
1 May 2019
January 25, 2023
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2023/01/25/
November 23, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/11/23/
COVID-19 and obesity, AKI, DKA, antibiotics, symptom checkers, hospital prep
Acute kidney injury (AKI) and diabetic ketoacidosis (DKA) were worse with COVID-19, antibiotics were overused, and an online symptom checker didn't triage safely, but most hospitals had enough ICU beds and preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://acphospitalist.acponline.org/weekly/archives/2021/03/17/1.htm
17 Mar 2021
Mixed results for remdesivir, negative results for canakinumab, and new vaccine information
Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
https://acphospitalist.acponline.org/weekly/archives/2021/07/21/1.htm
21 Jul 2021
March 2014
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2014/03/
De-escalation of antibiotics effective in Enterobacterales bacteremia, Spanish trial finds
The pragmatic trial found similarly high cure rates and no difference in serious adverse events between patients who continued on an antipseudomonal beta-lactam and those de-escalated to an antibiotic without antipseudomonal activity.
https://acphospitalist.acponline.org/archives/2024/01/17/de-escalation-of-antibiotics-effective-in-enterobacterales-bacteremia-spanish-trial-finds.htm
17 Jan 2024